NASDAQ: POCI
Precision Optics Corporation Inc Stock

$4.99-0.16 (-3.11%)
Updated Feb 10, 2025
POCI Price
$4.99
Fair Value Price
N/A
Market Cap
$31.69M
52 Week Low
$3.47
52 Week High
$6.90
P/E
-7.92x
P/B
3.13x
P/S
1.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$18.98M
Earnings
-$3.80M
Gross Margin
28.7%
Operating Margin
-18.79%
Profit Margin
-20%
Debt to Equity
0.7
Operating Cash Flow
-$2M
Beta
0.33
Next Earnings
Feb 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

POCI Overview

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine POCI's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
A
POCI
Ranked
#41 of 49

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$8.12A
$33.25A
$4.65A
View Top Medical Stocks

Be the first to know about important POCI news, forecast changes, insider trades & much more!

POCI News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how POCI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

POCI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
POCI is good value based on its book value relative to its share price (3.13x), compared to the US Medical Instruments & Supplies industry average (4.11x)
P/B vs Industry Valuation
POCI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more POCI due diligence checks available for Premium users.

Valuation

POCI price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-7.92x
Industry
40.12x
Market
31x

POCI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.13x
Industry
4.11x
POCI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

POCI's financial health

Profit margin

Revenue
$4.2M
Net Income
-$1.3M
Profit Margin
-31.2%
POCI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
POCI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.2M
Liabilities
$7.1M
Debt to equity
0.7
POCI's short-term assets ($7.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
POCI's short-term assets ($7.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
POCI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
POCI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$318.6k
Investing
-$28.1k
Financing
$577.0k
POCI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

POCI vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
POCIC$31.69M-3.11%-7.92x3.13x
FEMYD$26.56M-1.69%-1.43x4.45x
RVPC$24.28M+3.31%-1.50x0.29x
MBOTD$39.11M-9.41%-2.89x10.27x
NXGLC$22.07M-1.81%-5.51x4.71x

Precision Optics Corporation Stock FAQ

What is Precision Optics Corporation's quote symbol?

(NASDAQ: POCI) Precision Optics Corporation trades on the NASDAQ under the ticker symbol POCI. Precision Optics Corporation stock quotes can also be displayed as NASDAQ: POCI.

If you're new to stock investing, here's how to buy Precision Optics Corporation stock.

What is the 52 week high and low for Precision Optics Corporation (NASDAQ: POCI)?

(NASDAQ: POCI) Precision Optics Corporation's 52-week high was $6.90, and its 52-week low was $3.47. It is currently -27.68% from its 52-week high and 43.8% from its 52-week low.

How much is Precision Optics Corporation stock worth today?

(NASDAQ: POCI) Precision Optics Corporation currently has 6,350,170 outstanding shares. With Precision Optics Corporation stock trading at $4.99 per share, the total value of Precision Optics Corporation stock (market capitalization) is $31.69M.

Precision Optics Corporation stock was originally listed at a price of $1,856.27 in Dec 31, 1997. If you had invested in Precision Optics Corporation stock at $1,856.27, your return over the last 27 years would have been -99.73%, for an annualized return of -19.69% (not including any dividends or dividend reinvestments).

How much is Precision Optics Corporation's stock price per share?

(NASDAQ: POCI) Precision Optics Corporation stock price per share is $4.99 today (as of Feb 10, 2025).

What is Precision Optics Corporation's Market Cap?

(NASDAQ: POCI) Precision Optics Corporation's market cap is $31.69M, as of Feb 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Precision Optics Corporation's market cap is calculated by multiplying POCI's current stock price of $4.99 by POCI's total outstanding shares of 6,350,170.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.